We are analyzing https://link.springer.com/article/10.1007/s002800050406.

Title:
High-dose 7-hydroxymethotrexate: Acute toxicity and lethality in a rat model | Cancer Chemotherapy and Pharmacology
Description:
To elucidate mechanisms for methotrexate (MTX)-induced renal and hepatic toxicity, we investigated the acute effects of bolus plus continuous infusion of up to 0.4 g/kg 7-hydroxymethotrexate (7-OH-MTX) in the rat. We demonstrate for the first time in any species the occurrence of acute lethal toxicity within a few hours after 7-OH-MTX administration. Serum concentrations of 7-OH-MTX measured at the time of death were 1.4 mM (mean), about one-half of those achieved in some patients after infusion of high-dose MTX (HD-MTX) in the clinic. The data suggest an approximate LD50 (the dose lethal to 50% of the study population) of 0.3 g/kg and a steep dose/ lethality curve for 7-OH-MTX. Moreover, acute renal and hepatic toxicity occurred as evidenced by severe morphological findings and increased serum levels of creatinine and liver transaminases. In all rats subjected to continuous infusion of 7-OH-MTX, yellow microscopic precipitations were apparent in the kidney tubules. Crystallization was also seen in bile ducts of the liver in some of the rats. These results further support that the formation of 7-OH-MTX is disadvantageous and that reported attempts to prevent its formation during MTX treatment are warranted.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Education
Health & Fitness
Science

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We don't see any clear sign of profit-making.

While profit motivates many websites, others exist to inspire, entertain, or provide valuable resources. Websites have a variety of goals. And this might be one of them. Link.springer.com has a secret sauce for making money, but we can't detect it yet.

Keywords {🔍}

google, scholar, methotrexate, pubmed, cas, article, cancer, hydroxymethotrexate, highdose, toxicity, pharmacol, acute, tromsø, rat, renal, administration, ohmtx, dose, therapy, clinical, chemother, aarbakke, pharmacokinetics, chemotherapy, bremnes, liver, med, biochem, rep, res, privacy, cookies, content, research, pharmacology, smeland, patients, mtx, rats, leukemia, chem, arthritis, clin, department, institute, university, norway, data, information, publish,

Topics {✒️}

4-amino-4-deoxy-n10-methyl-pteroylglutamic acid 4-deoxy-4-amino-n10-methylpteroic acid month download article/chapter drug-related deaths secondary high-dose methotrexate therapy high-dose methotrexate regimens john sigurd svendsen acute lymphoblastic leukemia ole martin fuskevåg high-dose methotrexate treatment methotrexate anti-cancer therapy high-dose methotrexate infusion article cancer chemotherapy full article pdf high-dose methotrexate administration methotrexate-induced renal failure privacy choices/manage cookies acute lymphocytic leukemia low-dose methotrexate high dose methotrexate high-dose methotrexate acute lethal toxicity ehrlich ascites tumor evaluating preoperative chemotherapy high-dose 7-hydroxymethotrexate low-magnesium diet article smeland bremnes rm intermediate-dose methotrexate severe morphological findings renal failure induced high-dose mtx dosedependent acute hepatitis related subjects norwegian cancer society european economic area yellow microscopic precipitations uhplc-ms/ms postoperative wound infection folate-dependent enzymes light microscopic findings van der klein redetzki je olav aakre foundation dose lethal barrueco jr jacobs sa conditions privacy policy dose-dependent metabolism 7-hydroxy deoxyaminopteroic acid

Schema {🗺️}

WebPage:
      mainEntity:
         headline:High-dose 7-hydroxymethotrexate: Acute toxicity and lethality in a rat model
         description:To elucidate mechanisms for methotrexate (MTX)-induced renal and hepatic toxicity, we investigated the acute effects of bolus plus continuous infusion of up to 0.4 g/kg 7-hydroxymethotrexate (7-OH-MTX) in the rat. We demonstrate for the first time in any species the occurrence of acute lethal toxicity within a few hours after 7-OH-MTX administration. Serum concentrations of 7-OH-MTX measured at the time of death were 1.4 mM (mean), about one-half of those achieved in some patients after infusion of high-dose MTX (HD-MTX) in the clinic. The data suggest an approximate LD50 (the dose lethal to 50% of the study population) of 0.3 g/kg and a steep dose/ lethality curve for 7-OH-MTX. Moreover, acute renal and hepatic toxicity occurred as evidenced by severe morphological findings and increased serum levels of creatinine and liver transaminases. In all rats subjected to continuous infusion of 7-OH-MTX, yellow microscopic precipitations were apparent in the kidney tubules. Crystallization was also seen in bile ducts of the liver in some of the rats. These results further support that the formation of 7-OH-MTX is disadvantageous and that reported attempts to prevent its formation during MTX treatment are warranted.
         datePublished:
         dateModified:
         pageStart:415
         pageEnd:422
         sameAs:https://doi.org/10.1007/s002800050406
         keywords:
            7-Hydroxymethotrexate
            Toxicity
            Lethal dose
            Rat
            Oncology
            Pharmacology/Toxicology
            Cancer Research
         image:
         isPartOf:
            name:Cancer Chemotherapy and Pharmacology
            issn:
               1432-0843
               0344-5704
            volumeNumber:37
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer-Verlag
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Eivind Smeland
               affiliation:
                     name:University of Tromsø
                     address:
                        name:Department of Pharmacology, Institute of Medical Biology, University of Tromsø, Tromsø, Norway
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Ole Martin Fuskevåg
               affiliation:
                     name:University of Tromsø
                     address:
                        name:Department of Pharmacology, Institute of Medical Biology, University of Tromsø, Tromsø, Norway
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Kirsten Nymann
               affiliation:
                     name:University of Tromsø
                     address:
                        name:Department of Chemistry, Institute of Clinical Medicine, University of Tromsø, Tromsø, Norway
                        type:PostalAddress
                     type:Organization
               type:Person
               name:John Sigurd Svendsen
               affiliation:
                     name:University of Tromsø
                     address:
                        name:Department of Chemistry, Institute of Clinical Medicine, University of Tromsø, Tromsø, Norway
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Randi Olsen
               affiliation:
                     name:University of Tromsø
                     address:
                        name:Department of Morphology, Institute of Medical Biology, University of Tromsø, Tromsø, Norway
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Sigurd Lindal
               affiliation:
                     name:University of Tromsø
                     address:
                        name:Department of Morphology, Institute of Medical Biology, University of Tromsø, Tromsø, Norway
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Roy M. Bremnes
               affiliation:
                     name:University of Tromsø
                     address:
                        name:Department of Oncology, Institute of Clinical Medicine, University of Tromsø, Tromsø, Norway
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Jarle Aarbakke
               affiliation:
                     name:University of Tromsø
                     address:
                        name:Department of Pharmacology, Institute of Medical Biology, University of Tromsø, Tromsø, Norway
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:High-dose 7-hydroxymethotrexate: Acute toxicity and lethality in a rat model
      description:To elucidate mechanisms for methotrexate (MTX)-induced renal and hepatic toxicity, we investigated the acute effects of bolus plus continuous infusion of up to 0.4 g/kg 7-hydroxymethotrexate (7-OH-MTX) in the rat. We demonstrate for the first time in any species the occurrence of acute lethal toxicity within a few hours after 7-OH-MTX administration. Serum concentrations of 7-OH-MTX measured at the time of death were 1.4 mM (mean), about one-half of those achieved in some patients after infusion of high-dose MTX (HD-MTX) in the clinic. The data suggest an approximate LD50 (the dose lethal to 50% of the study population) of 0.3 g/kg and a steep dose/ lethality curve for 7-OH-MTX. Moreover, acute renal and hepatic toxicity occurred as evidenced by severe morphological findings and increased serum levels of creatinine and liver transaminases. In all rats subjected to continuous infusion of 7-OH-MTX, yellow microscopic precipitations were apparent in the kidney tubules. Crystallization was also seen in bile ducts of the liver in some of the rats. These results further support that the formation of 7-OH-MTX is disadvantageous and that reported attempts to prevent its formation during MTX treatment are warranted.
      datePublished:
      dateModified:
      pageStart:415
      pageEnd:422
      sameAs:https://doi.org/10.1007/s002800050406
      keywords:
         7-Hydroxymethotrexate
         Toxicity
         Lethal dose
         Rat
         Oncology
         Pharmacology/Toxicology
         Cancer Research
      image:
      isPartOf:
         name:Cancer Chemotherapy and Pharmacology
         issn:
            1432-0843
            0344-5704
         volumeNumber:37
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer-Verlag
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Eivind Smeland
            affiliation:
                  name:University of Tromsø
                  address:
                     name:Department of Pharmacology, Institute of Medical Biology, University of Tromsø, Tromsø, Norway
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Ole Martin Fuskevåg
            affiliation:
                  name:University of Tromsø
                  address:
                     name:Department of Pharmacology, Institute of Medical Biology, University of Tromsø, Tromsø, Norway
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Kirsten Nymann
            affiliation:
                  name:University of Tromsø
                  address:
                     name:Department of Chemistry, Institute of Clinical Medicine, University of Tromsø, Tromsø, Norway
                     type:PostalAddress
                  type:Organization
            type:Person
            name:John Sigurd Svendsen
            affiliation:
                  name:University of Tromsø
                  address:
                     name:Department of Chemistry, Institute of Clinical Medicine, University of Tromsø, Tromsø, Norway
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Randi Olsen
            affiliation:
                  name:University of Tromsø
                  address:
                     name:Department of Morphology, Institute of Medical Biology, University of Tromsø, Tromsø, Norway
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Sigurd Lindal
            affiliation:
                  name:University of Tromsø
                  address:
                     name:Department of Morphology, Institute of Medical Biology, University of Tromsø, Tromsø, Norway
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Roy M. Bremnes
            affiliation:
                  name:University of Tromsø
                  address:
                     name:Department of Oncology, Institute of Clinical Medicine, University of Tromsø, Tromsø, Norway
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Jarle Aarbakke
            affiliation:
                  name:University of Tromsø
                  address:
                     name:Department of Pharmacology, Institute of Medical Biology, University of Tromsø, Tromsø, Norway
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Cancer Chemotherapy and Pharmacology
      issn:
         1432-0843
         0344-5704
      volumeNumber:37
Organization:
      name:Springer-Verlag
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:University of Tromsø
      address:
         name:Department of Pharmacology, Institute of Medical Biology, University of Tromsø, Tromsø, Norway
         type:PostalAddress
      name:University of Tromsø
      address:
         name:Department of Pharmacology, Institute of Medical Biology, University of Tromsø, Tromsø, Norway
         type:PostalAddress
      name:University of Tromsø
      address:
         name:Department of Chemistry, Institute of Clinical Medicine, University of Tromsø, Tromsø, Norway
         type:PostalAddress
      name:University of Tromsø
      address:
         name:Department of Chemistry, Institute of Clinical Medicine, University of Tromsø, Tromsø, Norway
         type:PostalAddress
      name:University of Tromsø
      address:
         name:Department of Morphology, Institute of Medical Biology, University of Tromsø, Tromsø, Norway
         type:PostalAddress
      name:University of Tromsø
      address:
         name:Department of Morphology, Institute of Medical Biology, University of Tromsø, Tromsø, Norway
         type:PostalAddress
      name:University of Tromsø
      address:
         name:Department of Oncology, Institute of Clinical Medicine, University of Tromsø, Tromsø, Norway
         type:PostalAddress
      name:University of Tromsø
      address:
         name:Department of Pharmacology, Institute of Medical Biology, University of Tromsø, Tromsø, Norway
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Eivind Smeland
      affiliation:
            name:University of Tromsø
            address:
               name:Department of Pharmacology, Institute of Medical Biology, University of Tromsø, Tromsø, Norway
               type:PostalAddress
            type:Organization
      name:Ole Martin Fuskevåg
      affiliation:
            name:University of Tromsø
            address:
               name:Department of Pharmacology, Institute of Medical Biology, University of Tromsø, Tromsø, Norway
               type:PostalAddress
            type:Organization
      name:Kirsten Nymann
      affiliation:
            name:University of Tromsø
            address:
               name:Department of Chemistry, Institute of Clinical Medicine, University of Tromsø, Tromsø, Norway
               type:PostalAddress
            type:Organization
      name:John Sigurd Svendsen
      affiliation:
            name:University of Tromsø
            address:
               name:Department of Chemistry, Institute of Clinical Medicine, University of Tromsø, Tromsø, Norway
               type:PostalAddress
            type:Organization
      name:Randi Olsen
      affiliation:
            name:University of Tromsø
            address:
               name:Department of Morphology, Institute of Medical Biology, University of Tromsø, Tromsø, Norway
               type:PostalAddress
            type:Organization
      name:Sigurd Lindal
      affiliation:
            name:University of Tromsø
            address:
               name:Department of Morphology, Institute of Medical Biology, University of Tromsø, Tromsø, Norway
               type:PostalAddress
            type:Organization
      name:Roy M. Bremnes
      affiliation:
            name:University of Tromsø
            address:
               name:Department of Oncology, Institute of Clinical Medicine, University of Tromsø, Tromsø, Norway
               type:PostalAddress
            type:Organization
      name:Jarle Aarbakke
      affiliation:
            name:University of Tromsø
            address:
               name:Department of Pharmacology, Institute of Medical Biology, University of Tromsø, Tromsø, Norway
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Department of Pharmacology, Institute of Medical Biology, University of Tromsø, Tromsø, Norway
      name:Department of Pharmacology, Institute of Medical Biology, University of Tromsø, Tromsø, Norway
      name:Department of Chemistry, Institute of Clinical Medicine, University of Tromsø, Tromsø, Norway
      name:Department of Chemistry, Institute of Clinical Medicine, University of Tromsø, Tromsø, Norway
      name:Department of Morphology, Institute of Medical Biology, University of Tromsø, Tromsø, Norway
      name:Department of Morphology, Institute of Medical Biology, University of Tromsø, Tromsø, Norway
      name:Department of Oncology, Institute of Clinical Medicine, University of Tromsø, Tromsø, Norway
      name:Department of Pharmacology, Institute of Medical Biology, University of Tromsø, Tromsø, Norway
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(177)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

4.04s.

LINK . SPRINGER . COM {}